Karen Katz - Jan 25, 2022 Form 4 Insider Report for Casper Sleep Inc. (CSPR)

Role
Director
Signature
/s/ Michael Monahan, Attorney-in-Fact for Karen Katz
Stock symbol
CSPR
Transactions as of
Jan 25, 2022
Transactions value $
-$276,083
Form type
4
Date filed
1/26/2022, 03:10 PM
Previous filing
Jan 18, 2022
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSPR Common Stock Disposed to Issuer -$276K -40K -100% $6.90 0 Jan 25, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSPR Stock Option Disposed to Issuer $0 -60K -100% $0.00* 0 Jan 25, 2022 Common Stock 60K $15.90 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Karen Katz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.
F2 In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.
F3 The options provided for vesting in equal monthly installments over a four year period commencing on May 11, 2019, and would have been fully vested and exercisable on April 11, 2023.
F4 In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.